Estrogen metabolite ratios and risk assessment of hormone-related cancers. Assay validation and prediction of cervical cancer risk.
Sepkovic
D W
DW
Strang-Cornell Cancer Research Laboratories, New York, New York 10021, USA.
Bradlow
H L
HL
Ho
G
G
Hankinson
S E
SE
Gong
L
L
Osborne
M P
MP
Fishman
J
J
D001706:Biopsy; D004964:Estriol / Q000378:metabolism; D002393:Estrogens, Catechol / Q000652:urine; D005260:Female; D006801:Humans; D006894:Hydroxyestrones / Q000652:urine*; D007124:Immunoenzyme Techniques; D008597:Menstrual Cycle; D011237:Predictive Value of Tests; D017697:Premenopause; D012016:Reference Values; D015203:Reproducibility of Results; D018570:Risk Assessment; D012307:Risk Factors; D011795:Surveys and Questionnaires; D002583:Uterine Cervical Neoplasms / Q000453:epidemiology* / Q000473:pathology / Q000652:urine; D014626:Vaginal Smears
D002393:Estrogens, Catechol; D006894:Hydroxyestrones; C026702:16-hydroxyestrone; D004964:Estriol; C024980:2-hydroxyestrone